Novo Nordisk shares plunge after forecasting steep drop in sales #health

when you of course get a pricing headwind on your GLP1 products VGOI and OMIC you feel the pressure of that more but um but also on the back of of course being a focused company and being the best in what we do we feel very confident that the volume buildup will happen um script by script and we have seen the early signals of that with our Vigovi pill launch so I'm very hopeful that while we're disappointing the investors today on a short-term price decrease they will be quite Happy to see that we will be a ...